Metabolic Syndrome: A Clinical and Molecular Perspective
Merck & Co., Inc., Rahway, NJ, USA (United States)
Abstract
The metabolic syndrome is a cluster of interrelated common clinical disorders, including obesity, insulin resistance, glucose intolerance, hypertension, and dyslipidemia (hypertriglyceridemia and low HDL cholesterol levels). According to recently defined criteria, the metabolic syndrome is prevalent and is associated with a greater risk of atherosclerotic cardiovascular disease than any of its individual components. Primary defects in energy balance that produce obesity (and visceral adiposity in particular) are sufficient to drive all aspects of the syndrome. Increased free fatty acids and lipid accumulation in certain organs are mediators of insulin resistance. Obesity also leads to a proinflammatory and…
Citation impact
- FWCI
- 27.39
- Percentile
- 100%
- References
- 103
Authors
2Topics & keywords
- Metabolic syndrome
- Insulin resistance
- Adiponectin
- Medicine
- Hypertriglyceridemia
- Dyslipidemia
- Adipokine
- Obesity
- Good health and well-being